2023 ESC Guidelines for the management of cardiomyopathies: Developed by the task force on the management of cardiomyopathies of the European Society of …

E Arbelo, A Protonotarios, JR Gimeno… - European heart …, 2023 - academic.oup.com
• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Cardiac pacing and lead devices management: 25 years of research at EP Europace journal

P Defaye, M Biffi, M El-Chami, S Boveda, M Glikson… - Europace, 2023 - academic.oup.com
Aims Cardiac pacing represents a key element in the field of electrophysiology and the
treatment of conduction diseases. Since the first issue published in 1999, EP Europace has …

Evaluation and management of cancer patients presenting with acute cardiovascular disease: a Clinical Consensus Statement of the Acute CardioVascular Care …

SA Gevaert, S Halvorsen, PR Sinnaeve… - … Heart Journal: Acute …, 2022 - academic.oup.com
Advances in treatment, common cardiovascular (CV) risk factors and the ageing of the
population have led to an increasing number of cancer patients presenting with acute CV …

Joint British Society consensus recommendations for magnetic resonance imaging for patients with cardiac implantable electronic devices

A Bhuva, G Charles-Edwards, J Ashmore, A Lipton… - Heart, 2024 - heart.bmj.com
Magnetic Resonance Imaging (MRI) is increasingly a fundamental component of the
diagnostic pathway across a range of conditions. Historically, the presence of a cardiac …

Remote monitoring of cardiac implantable electronic devices and disease management

N Varma, F Braunschweig, H Burri, G Hindricks… - Europace, 2023 - academic.oup.com
This reviews the transition of remote monitoring of patients with cardiac electronic
implantable devices from curiosity to standard of care. This has been delivered by …

The impact of particle radiotherapy on the functioning of cardiac implantable electronic devices: a systematic review of in vitro and in vivo studies according to PICO …

A Barcellini, V Dusi, A Mirandola, S Ronchi, G Riva… - La radiologia …, 2022 - Springer
The number of oncological patients who may benefit from proton beam radiotherapy (PBT)
or carbon ion radiotherapy (CIRT), overall referred to as particle radiotherapy (RT), is …

Cardiovascular Magnetic Resonance in Patients with Cardiac Electronic Devices: Evidence from a Multicenter Study

A Barison, F Ricci, AG Pavon, G Muscogiuri… - Journal of Clinical …, 2023 - mdpi.com
Background: Most recent cardiac implantable electronic devices (CIEDs) can safely undergo
a cardiovascular magnetic resonance (CMR) scan under certain conditions, but metal …

Imaging in patients with cardiovascular implantable electronic devices: part 1—imaging before and during device implantation. A clinical consensus statement of the …

I Stankovic, JU Voigt, H Burri, D Muraru… - European Heart …, 2024 - academic.oup.com
More than 500 000 cardiovascular implantable electronic devices (CIEDs) are implanted in
the European Society of Cardiology countries each year. The role of cardiovascular imaging …

Cardiac Magnetic Resonance and Cardiac Implantable Electronic Devices: Are They Truly Still “Enemies”?

M Fogante, G Volpato, P Esposto Pirani, F Cela… - Medicina, 2024 - mdpi.com
The application of cardiac magnetic resonance (CMR) imaging in clinical practice has grown
due to technological advancements and expanded clinical indications, highlighting its …

New-generation electronic appliances and cardiac implantable electronic devices: a systematic literature review of mechanisms and in vivo studies

J Kewcharoen, K Shah, R Bhardwaj… - Journal of Interventional …, 2024 - Springer
Introduction Cardiac implantable electronic device (CIED) functions are susceptible to
electromagnetic interference (EMI) from electromagnetic fields (EMF). Data on EMI risks from …